Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: Results from the national cancer database by A. Martini, J. Pfail, U.G. Falagario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, A. Necchi, F. Montorsi, A. Briganti, J. Daza, P.J. Treacy, M.D. Galsky, J.P. Sfakianos

Get full text

The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE... by D. Cignoli, A. Martini, J.P. Sfakianos, G. Gandaglia, N. Fossati, A. Salonia, F. Barletta, S. Scuderi, D. Robesti, C.A. Bravi, E. Mazzone, G. Rosiello, G. Fallara, L. Nocera, G.O. Cirulli, A. Stabile, A. Briganti, F. Montorsi, W.K. Oh, E.D. Gallagher, M.D. Galsky

Get full text

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database by G. Sorce, A. Martini, J. Pfail, U.G. Falgario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, D. Cignoli, G. Basile, L. Nocera, G. Rosiello, E. Mazzone, C.A. Bravi, A. Necchi, F. Montorsi, A. Briganti, M.D. Galsky, J.P. Sfakianos

Get full text

Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data by A. Martini, A.B. Parikh, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, R. Leni, V. Cucchiara, C.A. Bravi, E. Mazzone, G. Rosiello, G. Basile, L. Nocera, A. Necchi, M. Moschini, J.P. Sfakianos, M.D. Galsky, W.K. Oh, C. Tsao, F. Montorsi, A. Briganti

Get full text